Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Guilford, RPR amend Gliadel marketing and distribution agreement

Oct. 1, 1998

IB-367: preclinical results presented at ICAAC support clinical trials in oral mucositis

Sep. 30, 1998

Celgene initiates development of Thalomid for hematological cancers

Sep. 30, 1998

Pharmacyclics starts phase III Gd-Tex trial for brain metastases

Sep. 28, 1998

Polish researchers present new antitumor agents

Sep. 28, 1998

Investigators at C&C Research design new antiestrogenic agents

Sep. 28, 1998

HMR grants Matrix rights to anticancer agent about to enter phase II

Sep. 25, 1998

Oxigene updates Neu-Sensamide development status

Sep. 25, 1998

Biomira and Biovector collaborate on development of idiotypic B-cell lymphoma vaccine

Sep. 24, 1998

New paclitaxel formulation enters clinical trials

Sep. 24, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.